Functional Modulation of the Glucocorticoid Receptor and Suppression of NF-κB-dependent Transcription by Ursodeoxycholic Acid
Open Access
- 1 December 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (50), 47371-47378
- https://doi.org/10.1074/jbc.m107098200
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- How NF-κB is activated: the role of the IκB kinase (IKK) complexOncogene, 1999
- Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosisHepatology, 1999
- Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosisJournal of Hepatology, 1999
- Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress NF‐κB‐dependent transcriptionFEBS Letters, 1998
- A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.Journal of Clinical Investigation, 1998
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosisDigestive Diseases and Sciences, 1996
- Effects of ursodeoxycholic acid and chenodeoxycholic acid on major histocompatibility complex class I gene expressionThe Esophagus, 1996
- Differential Effects of Chenodeoxycholic and Ursodeoxycholic Acids on Interleukin 1, Interleukin 6 and Tumor Necrosis Factor-α Production by MonocytesHepatology, 1992
- Immunomodulatory Effects of Ursodeoxycholic Acid on Immune ResponsesHepatology, 1992